Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial.

Trial Profile

Vaginal DHEA for Vaginal Symptoms: A Phase III Randomized, Double Blind, Placebo- Controlled Trial.

Active, no longer recruiting
Phase of Trial: Phase III

Latest Information Update: 25 Feb 2013

At a glance

  • Drugs Prasterone (Primary)
  • Indications Atrophic vaginitis; Menopausal syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Feb 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
    • 24 Jan 2013 New source identified and integrated (Mayo Clinic).
    • 17 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top